Bionano Genomics Q2 2024 GAAP EPS $(0.24) Beats $(0.42) Estimate, Sales $7.771M Miss $8.003M Estimate
Bionano Genomics Q2 2024 GAAP EPS $(0.24) Beats $(0.42) Estimate, Sales $7.771M Miss $8.003M Estimate
bionano genomics 2024年Q2 GAAP每股收益为$(0.24)，超出$(0.42)的预期，并且销售额为777.1万美元，低于预期的800.3万美元。
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.42) by 42.86 percent. This is a 80.65 percent increase over losses of $(1.24) per share from the same period last year. The company reported quarterly sales of $7.771 million which missed the analyst consensus estimate of $8.003 million by 2.90 percent. This is a 10.29 percent decrease over sales of $8.662 million the same period last year.
bionano genomics（纳斯达克：BNGO）报告了每股亏损0.24美元，超出了分析师预期的0.42美元的42.86％。这比去年同期每股亏损1.24美元增加了80.65％。该公司报告的季度销售额为777.1万美元，较分析师预计的800.3万美元低2.90％。这是去年同期销售额的10.29％降低。